Dr. Premsrirut is a co-founder and President and CEO of Mirimus, Inc., a company at the forefront of developing RNA interference and CRISPR gene editing technologies and investigating their potential therapeutic applications. At the start of the COVID-19 pandemic, Dr. Premsrirut led her team in a call to action to address the lack of inefficient testing methods that would be required to reopen our schools and economy. Her team quickly developed a fast, cost-effective and scalable solution to increase the overall capacity of COVID-19 testing using saliva-based pool testing. This SalivaClear TM solution is now used by over 500 schools, community centers, shelters and businesses across the nation for surveillance testing to quickly identify infected individuals in group settings and interrupt the chains of transmission. Her team was named a winner in the XPRIZE Rapid COVID-19 Testing Competition for their innovative strategy and is now scaling this approach across the country.